1. Home
  2. STRA vs KARD Comparison

STRA vs KARD Comparison

Compare STRA & KARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Strategic Education Inc.

STRA

Strategic Education Inc.

HOLD

Current Price

$82.39

Market Cap

1.9B

Sector

Real Estate

ML Signal

HOLD

Logo Kardigan Inc. Common Stock

KARD

Kardigan Inc. Common Stock

N/A

Current Price

$14.20

Market Cap

1.9B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
STRA
KARD
Founded
2017
2023
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.9B
IPO Year
1996
2026

Fundamental Metrics

Financial Performance
Metric
STRA
KARD
Price
$82.39
$14.20
Analyst Decision
Buy
Strong Buy
Analyst Count
3
4
Target Price
★ $96.67
$42.25
AVG Volume (30 Days)
208.0K
★ 638.3K
Earning Date
11-05-2026
11-22-2026
Dividend Yield
★ 2.98%
N/A
EPS Growth
★ 15.85
N/A
EPS
★ 3.19
N/A
Revenue
★ $997,137,000.00
N/A
Revenue This Year
$2.51
N/A
Revenue Next Year
$2.96
N/A
P/E Ratio
$25.22
★ N/A
Revenue Growth
★ 57.23
N/A
52 Week Low
$69.70
$12.23
52 Week High
$89.73
$27.00

Technical Indicators

Market Signals
Indicator
STRA
KARD
Relative Strength Index (RSI) 57.63 36.32
Support Level $77.55 $13.75
Resistance Level $85.36 $22.81
Average True Range (ATR) 2.20 1.30
MACD 0.46 -0.02
Stochastic Oscillator 94.72 34.46

Price Performance

Historical Comparison
STRA
KARD

About STRA Strategic Education Inc.

Strategic Education Inc. is an education services company that provides access to high-quality education through campus-based and online post-secondary education offerings, as well as through programs to develop job-ready skills for high-demand markets. The company operates through wholly-owned subsidiaries Strayer University and Capella University, both accredited post-secondary institutions of higher education located in the United States, as well as Torrens University, an accredited post-secondary institution of higher education located in Australia. It provide employees with access to affordable and industry relevant training, certificate, and degree programs. The reportable segments of the company are U.S. Higher Education, Australia/New Zealand and Education Technology Services.

About KARD Kardigan Inc. Common Stock

Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.

Share on Social Networks: